Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT06574204

Clinical Observations of Pain and Pruritus Induced by Exposure to Allergic Contact Dermatitis Caused by Macrolides

The Mechanism and Clinical Observations of Pain and Pruritus Induced by Exposure to Allergic Contact Dermatitis Resulting From Macrolides

Status
Not Yet Recruiting
Phase
Study type
Observational
Enrollment
30 (estimated)
Sponsor
Affiliated Hospital of Nantong University · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

Clinical side effects of macrolides in addition to the common gastrointestinal reactions, recently it has been found that the incidence of local reactions after injection is relatively high, such as pain and itching and local inflammation. Severe skin reactions include erythema multiforme, acute systemic eruption impetigo, Stevens-Johnson syndrome, toxic epidermal necrolysis, and drug reactions with eosinophilia and systemic symptoms. The clinical study is a single-center, randomized, open, single-dose trial design. The clinical study plans to enroll 30 subjects to evaluate the incidence and severity of pain and pruritus after a single skin test in healthy subjects. A total of 30 subjects were randomly divided into 2 groups with 15 cases in each group. Erythromycin or azithromycin skin test will be performed on the left hand, and the same amount of normal saline will be injected into the right hand as the control. This clinical observation experiment helps improve the side effects and promotes upgrading macrolide antibiotics during clinical application.

Conditions

Interventions

TypeNameDescription
DRUGErythromycinThe researchers injected 30 units of erythromycin into the inner right wrist of the subjects, which is a liquid dosage form.
DRUGAzithromycinThe researchers injected 30 units of azithromycin into the inner right wrist of the subjects, which is a liquid dosage form.
OTHERphysiological salineThe researchers injected 10-20 μl of physiological saline into the inner left wrist of the subjects, which is a liquid dosage form.

Timeline

Start date
2024-09-01
Primary completion
2024-12-31
Completion
2024-12-31
First posted
2024-08-27
Last updated
2024-08-27

Source: ClinicalTrials.gov record NCT06574204. Inclusion in this directory is not an endorsement.